Heron Therapeutics is a pharmaceutical company that develops and sells medicines for patients receiving cancer treatment and for pain relief after surgery. Its products address chemotherapy-induced nausea and vomiting and postoperative pain, and are used by hospitals, clinics and healthcare professionals. The company is based in the United States and focuses on acute care and supportive care treatments for patients and the clinicians who treat them.
The shares are listed on the London Exchange in UK under the code 0J4V, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3742 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
2/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-51.5%
From 52-week high-76.3%
MomentumWeak
9/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-11.4%
6-month return-60.9%
12-month, skipping last month-77.4%
Stability (higher is calmer)Weak
5/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)97.1%
Worst drawdown, 1 year (smaller is calmer)-83.1%
LiquidityWeak
14/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.261 – 1.570Daily closes, split-adjusted
Signals
50-day average0.339
200-day average0.767
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.031
Technical summary
Daily
Neutral
7 bullish · 4 neutral · 5 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
0.38
Bearish
EMA 10
0.37
Bullish
SMA 20
0.34
Bullish
EMA 20
0.35
Bullish
SMA 50
0.34
Bullish
EMA 50
0.37
Bullish
SMA 100
0.42
Bearish
EMA 100
0.47
Bearish
SMA 200
0.77
Bearish
EMA 200
0.71
Bearish
Oscillators (daily)
RSI (14)
54.70
Neutral
MACD (12, 26)
0.01
Bullish
Momentum (12)
17.79
Bullish
Stochastic %K (14)
62.86
Neutral
Williams %R (14)
-37.14
Neutral
CCI (20)
54.87
Neutral
Pivot points (classic, last session)
S3
0.32
S2
0.34
S1
0.35
Pivot
0.37
R1
0.38
R2
0.40
R3
0.41
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
